About Cytera
Cytera is a company based in London (United Kingdom) founded in 2016 by Ignacio Willats and Ali Afshar. Cytera has raised $150 thousand across 1 funding round from investors including Y Combinator. Cytera operates in a competitive market with competitors including Multiply Labs, Shenzhen Shenyan Biotechnology, ThermoGenesis, Cellular Origins and Guangdong Bogong Medical Technology, among others.
- Headquarter London, United Kingdom
- Founders Ignacio Willats, Ali Afshar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$150 K (USD)
in 1 rounds
-
Latest Funding Round
$150 K (USD), Seed
Aug 21, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cytera
Unlock access to complete
Unlock access to complete
Funding Insights of Cytera
Cytera has successfully raised a total of $150K through 1 strategic funding round. The most recent funding activity was a Seed round of $150 thousand completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytera
Cytera has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Cytera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytera
Investment portfolio details for Cytera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytera
Detailed financials for Cytera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytera Comparisons
Peer comparison for Cytera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytera
Cytera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multiply Labs, Shenzhen Shenyan Biotechnology, ThermoGenesis, Cellular Origins and Guangdong Bogong Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicines are manufactured via robotic systems for cell therapies.
|
|
| Locked | Locked | Locked |
Automated cell processing systems are developed for gene therapies.
|
|
| Locked | Locked | Locked |
Automated technologies for cell-based therapeutics and bio-processing are developed.
|
|
| Locked | Locked | Locked |
Automates cell therapy manufacturing through partnerships and robotics integration.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of Cytera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytera
Complete news archive for Cytera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytera
Cytera was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Cytera is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Ali Afshar is the current CEO of Cytera. They have also founded this company.
Cytera is a funded company, having raised a total of $150K across 1 funding round to date.
Cytera was founded in 2016 in London, United Kingdom, within the biotechnology sector. Devices for automated culturing of animal and human cells are produced, incorporating T-flasks and incubators to minimize errors and labor in drug development and cell therapy applications. A closed system is utilized to prevent contamination, while protocols and schedules are made adjustable and automated for operational flexibility.
Cytera's top competitors include Multiply Labs, Celltrio and ThermoGenesis.
Cytera has 1 investor. Key investors include Y Combinator.